Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or Cytosine arabinoside

Treatment of choroidal melanoma by chemotherapy is usually unsuccessful, with response rates of less than 1% reported for dacarbazine (DTIC)-containing regimens which show 20% or more response rates in skin melanoma. Recently, we reported the activity of several cytotoxic agents against primary chor...

Descripción completa

Detalles Bibliográficos
Autores principales: Neale, M H, Myatt, N, Cree, I A, Kurbacher, C M, Foss, A J E, Hungerford, J L, Plowman, P N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362718/
https://www.ncbi.nlm.nih.gov/pubmed/10188895
http://dx.doi.org/10.1038/sj.bjc.6690237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362718/
https://www.ncbi.nlm.nih.gov/pubmed/10188895
http://dx.doi.org/10.1038/sj.bjc.6690237

Ejemplares similares